We recently reported the synthesis and gastrointestinal prokinetic activity of novel benzamide derivatives with amphoteric side chains.
(Et 3 N) as a base in DMF to give compound 15 in 93% yield. Since the usage of potassium carbonate (K 2 CO 3 ) as a base in this step produced a great deal of the byproduct, butyl 4-tertbutoxycarbonylamino-1-piperidinecarboxylate, we changed the base from K 2 CO 3 to Et 3 N. Next, the deprotection with hydrogen chloride-isopropyl alcohol solution of 15 followed by the removal of acid using Et 3 N gave a primary amine (16) quantitatively. Compound 7 was converted into the activated ester with ethyl chlorocarbonate (ClCO 2 Et) in anhydrous tetrahydrofuran (THF) and then amidated with 16 to give the desired ester (1b) in good (84%) yield.
In conclusion, we have established an efficient route for the synthesis of 1b, a novel promising gastro-and colon-prokinetic agent. The new route shortened the total steps of the synthesis of 1b and consequently improved significantly the total yield (14%→65%) from the starting material 2. Furthermore, this route was found to be applicable to the large-scale synthesis of 1b. Pre-clinical studies on 1b (AU-224) are now in progress.
Experimental
All melting points were measured on a Yanagimoto melting point apparatus and are uncorrected. Spectral data were obtained using the following apparatus:
1 H-NMR spectra with JEOL LA-300 (300 MHz) and JEOL A-500 (500 MHz) spectrometers; mass spectra (MS) with a JEOL JMS-DX 300 mass spectrometer; IR spectra with a Hitachi 270-30 spectrometer. Chemical shifts are expressed as d (ppm) values with tetramethylsilane (TMS) as an internal standard. Elemental analyses were performed using Yanagimoto MT-5 or MT-6 elemental analysis apparatus. TLC was conducted on a 0.25 mm pre-coated silica gel plate (60F 254 , Merck), and spots were detected by inspection under short (254 nm) wavelength UV light, or by the colors developed with iodine. Organic extracts were dried over anhydrous Na 2 SO 4 . A new and facile route for the synthesis of the novel gastrointestinal prokinetic butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (1b), which exhibited potent gastro-and colon-prokinetic activities by oral administration without significant side effects, was established. The key intermediate, butyl 4-amino-1-piperidineacetate (16), was prepared from commercially available 4-amino-1-benzylpiperidine (2) in a high yield with four steps. Compound 1b was prepared by condensation of commercially available 4-amino-5-choloro-2-methoxybenzoic acid (7) with 16 in 84% yield. This improved synthetic route was appropriate for large-scale synthesis of 1b.
An Improved Synthesis of Butyl 4-[(4-
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The solvent was evaporated under reduced pressure.
N-(1-Benzyl-4-piperidyl)-tert-butoxycarbamate (11) A solution of Boc 2 O (1150 g, 5.27 mol) in CH 3 CN (2.0 l) was added to a solution of 4-amino-1-benzylpiperidine (1002 g, 5.27 mol) in CH 3 CN (8.0 l) and the mixture was stirred at room temperature for 1 h. The reaction mixture was concentrated and the resultant crystal was filtered and washed with CH 3 CN to give 1383 g of 11 (90%) as a colorless crystal, mp 122-123°C (lit. Butyl Chloroacetate (14) Chloroacetyl chloride (3000 g, 26.6 mol) was added to n-BuOH (2.55 l, 27.9 mol) under ice-cooling, and the mixture was left for 0 d in a sealed tube. Water and iso-Pr 2 O (9.0 l) were added to the mixture and the organic layer was separated. The organic layer was washed with saturated NaCl and dried. The solvent was evaporated and the residue was distilled under reduced pressure and nitrogen atmosphere to give 3675 g of 14 (92%) as colorless liquid, bp 100 100-115°C (lit. 4a) : bp 20 81°C, lit. Butyl 4-tert-Butoxycarbonylamino-1-piperidineacetate (15) A solution of 14 (0.79 g, 5.25 mmol) in DMF (4 ml) was added to a suspension of 12 (1.00 g, 4.99 mmol) and Et 3 N (0.72 ml, 5.25 mol) in DMF (6 ml) at 50°C and the mixture was stirred at 50°C for 1 h. Water was poured into the reaction mixture and the resultant crystal was collected and washed successively with water and heptane to give 1.46 g (93%) of 15 as a colorless crystal, mp 115.5-116.5°C. Anal. Calcd for C 16 H 30 N 2 O 4 : C, 61.12; H, 9.62; N, 8.91. Found: C, 60.90; H, 9.60; N, 8.88 Butyl 4-[(4-Amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (1b) A mixture of 7 (1065 g, 5.28 mol), Et 3 N (821 ml, 5.89 mol) and ClCO 2 Et (526 ml, 5.54 mol) in anhydrous THF (11 l) was stirred under ice cooling. After 1.5 h, a solution of 16 (1260 g, 5.88 mol) in anhydrous THF (2.4 l) was added dropwise to the mixture, and the mixture was stirred under ice cooling for 2 h. The insoluble substance was filtered off and the filtrate was concentrated. Methyl isobutyl ketone (MIBK) (12.6 l), water (4.2 l) and K 2 CO 3 (73 g) were added to the resultant residue. The MIBK layer was washed with saturated NaCl, dried and concentrated. 
